GLP-1 medications like semaglutide, tirzepatide, and liraglutide are helping more people take control of their weight and health
[1] [5] These medications bind to GLP-1 receptors primarily in the pancreas, brain, and gastrointestinal tract, leading to increased insulin secretion, reduced glucagon release, and enhanced satiety
Previous experiments have found that exendin-4 could reduce the pain-induced neuro-inflammatory response through the GLP-1R pathway, thereby promoting the recovery of cognitive function in mice (100)
Key genes like GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) influence appetite regulation and medication response
Omdat ik weet hoe leuk het is om uit te pakken, wordt iedere bestelling als een cadeautje ingepakt